Suggestions
Sonali Bloom
CEO, 20/20 Onsite: Expanding access to care by bringing primary eye care directly to patients and transforming clinical trials.
Sonali Bloom is the Chief Executive Officer at 20/20 Onsite, a company focused on transforming clinical trials and expanding access to healthcare by bringing services directly to patients. She has a strong background in healthcare innovation and entrepreneurship.
Professional Background
- Current Position: CEO at 20/20 Onsite
- Previous Roles:
- Senior Director of Operations & Client Experience at 20/20 Onsite (October 2018 - October 2019)
- Senior Director of Product Strategy at Decision Resources Group (September 2017 - October 2018)
- Co-founder and Chief Merchandising Officer at Curio Road (July 2012 - November 2013)
Education
- Harvard Business School: Master of Business Administration (MBA) with Distinction, focusing on Entrepreneurship, Strategy, and General Management (2015 - 2017)
- Yale University: Bachelor of Science in Physics
Skills and Interests
Sonali is passionate about innovation in healthcare and is dedicated to enhancing patient care through strategic leadership and operational excellence. She has experience in product strategy, operations management, and e-commerce.
Her LinkedIn profile highlights her commitment to improving healthcare delivery and her entrepreneurial spirit, showcasing her diverse skill set and leadership capabilities in the life sciences industry .123
Highlights
The rise of diabetes and obesity treatments will have tremendous benefits for patients - and for their families, communities, and society.
We've got our eyes on the recent studies that have revealed a link between these treatments and sight-threatening disorders. This underscores the critical need for ocular assessments in obesity and diabetes clinical trials.
At 20/20 Onsite, we provide eye assessments at the point of need for the patient, ensuring that all ocular endpoints are meticulously evaluated by certified professionals using state-of-the-art equipment. Our mobile clinics bring these services directly to clinical trial sites, enhancing patient care and trial outcomes.
If you’re involved in diabetes or obesity trials, don’t let ocular endpoints be a blind spot. Our expertise can help mitigate risks and ensure the success of your study.
https://lnkd.in/efEtnpnk
#ClinicalTrials #ObesityResearch #DiabetesResearch #EyeCare #PharmaInnovation #PatientSafety
Proud sister here, shamelessly promoting my brother Sahil Bloom's book, which launched today! Sahil, I am truly so proud of and inspired by the curiosity, creativity, and hard work that you invest in everything that you do.
